Sculptra Aesthetic

Sculptra Aesthetic is an FDA-approved injectable that helps gradually replace lost collagen—the most common protein in the body that is used to form a framework to support cell and tissue. Sculptra Aesthetic is made with biocompatible, biodegradable, synthetic material called poly-L-lactic acid, which is gradually and naturally absorbed by the body and helps to rebuild lost collagen through a series of treatments administered by a trained specialist. As a poly-L-lactic acid (PLLA) collagen stimulator, Sculptra Aesthetic helps restore the deep, underlying structure of the skin to diminish facial wrinkles.

Sculptra Aesthetic works with your body within the deep dermis to help revitalize collagen production and help restore your skin’s inner structure and volume.

As the Sculptra Aesthetic PLLA microparticles are absorbed, they help stimulate collagen production.

SCULPTRA AESTHETIC ADDRESSES AN UNDERLYING CAUSE OF FACIAL AGING, NOT JUST THE SYMPTOMS!

IMPORTANT SAFETY INFORMATION: Sculptra® Aesthetic (injectable poly-L-lactic acid) is indicated for use in people with healthy immune systems as a single regimen for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles in which deep dermal grid pattern (cross-hatch) injection technique is appropriate. Sculptra® Aesthetic should not be used by people that are allergic to any ingredient of the productor have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age. Sculptra® Aesthetic has unique injection requirements and should only be used by a trained medical professional. Contour deficiencies should not be overcorrected because they are expected to gradually improve after treatment. Sculptra® Aesthetic should not be injected into the blood vessels as it may cause vascular occlusion, infarction or embolic phenomena. Use at the site of skin sores, cysts, pimples, rashes, hives or infection should be postponed until healing is complete. Sculptra® Aesthetic should not be injected into the lip area (vermillion) of the lip or in the peri-orbital area. The most common side effects after initial treatment include injection site swelling, tenderness, redness, pain, bruising, bleeding, itching and lumps. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported. Sculptra® Aesthetic is available only through a licensed practitioner. View the complete instructions for use at www.SculptraAesthetic.com 1 Stein P, Vitavska O, Kind P, Hoppe W, Wieczorek H, Schürer NY. The biological basis for poly-L-lactic acid-induced augmentation. J Dermatol Sci. 2015;78:26-33. 2Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg.2013;39:915-922. 3 Sculptra® Aesthetic injectable poly-L-lactic acid. Instructions for Use. Fort Worth, TX: Galderma Laboratories, L.P., 2016. 4Brown SA, Rohrich RJ, Baumann L, et al. Subject global evaluation and subject satisfaction using injectable poly-Llactic acid versus human collagen for the correction of nasolabial fold wrinkles. Plast Reconstr Surg. 5Quan T, Wang F, Shao Y, et al. Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J Invest Dermatol. 2013 Mar;133(3):658-667. 6Ganjoo A. Aging skin. In: Venkataram M, ed. ACS(I) Textbook on Cutaneous and Aesthetic Surgery. 1st ed. New Delhi, India: Jaypee Brothers Medical Publishers; 2012:545-549. 7Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiosteal voluminization for perioral rejuvenation. J Drugs Dermatol.2008;7(3):209-220. 2011;127(4):1684-1692. 8Dermal Fillers Approved by the Center for Devices and Radiological Health. Accessed April 25 2018. Available at: https://www.fda.gov/medicaldevices/productsandmedicalprocedures/cosmeticdevices/wrinklefillers/ucm227749. htm#approved 9 Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft tissue contouring. Plast Reconstr Surg. 2006 Sep;118(3Suppl):55S-63S. © 2019 Galderma Laboratories, L.P. All trademarks are the property of their respectiveowners. USMP/SCA/0024/0418(1)